Psomagen, Inc.
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jan 2035
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 9 fees due Dec 4 to 25, 2026 · next Dec 4
- 19 fees due Jan 2 to 30, 2027 · next Jan 2
- 6 fees due Feb 13 to 27, 2027 · next Feb 13
- 3 fees due Mar 10 to 17, 2027 · next Mar 10
- 3 fees due Apr 3 to 10, 2027 · next Apr 3
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,663,831 | Method and system for microbiome analysis In force · From the USPTO record | In force | From the USPTO record | |
| US 10,242,160 | Method and System for Microbiome-Derived Diagnostics and Therapeutics In force · Low confidence | In force | Low confidence | |
| US 10,287,639 | Method and System for Microbiome Analysis In force · Low confidence | In force | Low confidence | |
| US 10,294,532 | Method and System for Microbiome Analysis In force · Low confidence | In force | Low confidence | |
| US 9,703,929 | Method and system for microbiome-derived diagnostics and therapeutics In force · From the USPTO record | In force | From the USPTO record | |
| US 9,710,606 | Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues In force · From the USPTO record | In force | From the USPTO record | |
| US 9,754,080 | Method and system for microbiome-derived characterization, diagnostics and therapeutics for cardiovascular disease conditions In force · From the USPTO record | In force | From the USPTO record | |
| US 9,758,839 | Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features In force · From the USPTO record | In force | From the USPTO record | |
| US 9,760,676 | Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions In force · From the USPTO record | In force | From the USPTO record | |
| US 10,073,952 | Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 95: 2 patents in force now held by others. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 pending · 1 abandoned · 6 no status recorded